Position in ARGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$228,568,250
-$159,827,871 QoQ
Shares Held
313,000
-32.2% QoQ
Ownership
0.503%
of shares outstanding
% of Portfolio
5.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bellevue Group AG holds $2,583,944,637 across 59 Biotechnology names. ARGX ranks #2 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
681,908 | $304,499,197 | |
| 2 | ARGX |
Argenx SE
This page
|
313,000 | $228,568,250 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
278,674 | $215,314,678 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
3,584,573 | $176,217,608 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,544,456 | $150,198,346 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
1,818,665 | $136,563,554 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,726,144 | $131,563,376 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
481,785 | $124,454,701 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $228,568,250 | 313,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $388,396,121 | 461,854 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $402,949,679 | 546,328 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $314,768,116 | 571,039 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $342,615,260 | 578,874 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $364,808,160 | 593,184 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $343,043,944 | 632,829 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $297,533,494 | 691,874 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $319,313,219 | 811,016 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $330,672,799 | 869,208 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $448,135,493 | 911,530 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $359,831,473 | 923,284 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $330,451,634 | 886,928 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $345,152,012 | 911,100 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $324,575,105 | 919,346 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $353,799,280 | 933,803 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $300,565,473 | 953,238 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $349,152,737 | 997,038 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $297,149,276 | 983,938 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $293,253,620 | 974,038 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $262,874,625 | 954,554 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $278,017,392 | 945,348 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $251,760,880 | 959,016 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $214,873,023 | 954,016 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $128,371,411 | 974,504 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||